Use of Glucagon-Like Peptide 1 Analogues and the Risk of Fracture in Type 2 Diabetes Patients

Johanna Driessen; Hein A. van Onzenoort; Arief Lalmohamed; Corinne Klop; Marloes Bazelier; Kees Neef; Frank de Vries

Use of Glucagon-Like Peptide 1 Analogues and the Risk of Fracture in Type 2 Diabetes Patients

Johanna Driessen
, Hein A. van Onzenoort
, Arief Lalmohamed
, Corinne Klop
, Marloes Bazelier
, Kees Neef
, Frank de Vries

Pharmacoepidemiology and Clinical Pharmacology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	513-513
Number of pages	1
Journal	Pharmacoepidemiology and Drug Safety
Volume	22
Publication status	Published - Oct 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{0d5966f1bec14403b1cac522cf0bb5f2,

title = "Use of Glucagon-Like Peptide 1 Analogues and the Risk of Fracture in Type 2 Diabetes Patients",

author = "Johanna Driessen and \{van Onzenoort\}, \{Hein A.\} and Arief Lalmohamed and Corinne Klop and Marloes Bazelier and Kees Neef and \{de Vries\}, Frank",

year = "2013",

month = oct,

language = "English",

volume = "22",

pages = "513--513",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Use of Glucagon-Like Peptide 1 Analogues and the Risk of Fracture in Type 2 Diabetes Patients

AU - Driessen, Johanna

AU - van Onzenoort, Hein A.

AU - Lalmohamed, Arief

AU - Klop, Corinne

AU - Bazelier, Marloes

AU - Neef, Kees

AU - de Vries, Frank

PY - 2013/10

Y1 - 2013/10

M3 - Article

SN - 1053-8569

VL - 22

SP - 513

EP - 513

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

ER -